What is iRadimed's EPS (diluted)?

iRadimed (IRMD) reported EPS (diluted) of $0.45 in Q1 2026.

How has iRadimed's EPS (diluted) changed year-over-year?

iRadimed's EPS (diluted) increased by 21.6% year-over-year, from $0.37 to $0.45.

What is the long-term trend for iRadimed's EPS (diluted)?

Over 4 years (2021 to 2025), iRadimed's EPS (diluted) has grown at a 24.0% compound annual growth rate (CAGR), from $0.74 to $1.75.

What does EPS (diluted) mean?

Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

iRadimed IRMD EPS (Diluted)

EPS (Diluted) at other companies

GE HealthCare TechnologiesGEHC

$0.85-30.9%

Merit Medical SystemsMMSI

$0.68+38.8%

ICU MedicalICUI

$1.20+290%

ITG

Integer HoldingsITGR

$0.48+173%

Lumexa Imaging Holdings, Inc. LMRI

$0.02+118%

RadNetRDNT

-$0.43+15.7%

Other financials

Income statement

See full

Revenue$22.0M+12.6%

Gross profit$16.8M+13.3%

Operating income$7.2M+33.2%

Net income$5.8M+24.1%

Balance sheet

See full

Cash & equivalents$56.4M+12.0%

Total debt$59.2K-96.9%

Total equity$98.5M+9.4%

Total assets$114.4M+12.4%

Cash flow

See full

Operating cash flow$8.3M+93.2%

CapEx$403.0K-89.1%

Free cash flow$7.9M+1,226%

Valuation

See full

Market cap$1.21B+84.4%

P/E51.3×+18.1×

P/S14×+5.3×

Profitability

See full

Gross margin76.8%-0.1pp

Operating margin32.4%+2.3pp

Net margin27.4%+1.0pp

FCF margin28.4%+8.9pp

Returns & leverage

See full

Return on equity25%+1.2pp

Debt / equity0×0.0×

Current ratio7.1×-1.7×

Where this comes from

Reported directly by iRadimed in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRadimed's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is iRadimed's EPS (diluted)?: iRadimed (IRMD) reported EPS (diluted) of $0.45 in Q1 2026.
How has iRadimed's EPS (diluted) changed year-over-year?: iRadimed's EPS (diluted) increased by 21.6% year-over-year, from $0.37 to $0.45.
What is the long-term trend for iRadimed's EPS (diluted)?: Over 4 years (2021 to 2025), iRadimed's EPS (diluted) has grown at a 24.0% compound annual growth rate (CAGR), from $0.74 to $1.75.
What does EPS (diluted) mean?: Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.